Your browser is no longer supported. Please, upgrade your browser.
Settings
LMAT LeMaitre Vascular, Inc. daily Stock Chart
LMAT [NASD]
LeMaitre Vascular, Inc.
Index- P/E34.44 EPS (ttm)0.88 Insider Own15.40% Shs Outstand20.23M Perf Week1.81%
Market Cap614.59M Forward P/E28.58 EPS next Y1.06 Insider Trans-15.10% Shs Float16.53M Perf Month-17.47%
Income17.90M PEG- EPS next Q0.16 Inst Own89.00% Short Float12.83% Perf Quarter-11.79%
Sales117.20M P/S5.24 EPS this Y33.00% Inst Trans9.11% Short Ratio16.58 Perf Half Y-4.10%
Book/sh7.16 P/B4.24 EPS next Y14.55% ROA11.40% Target Price36.00 Perf Year3.93%
Cash/sh2.22 P/C13.69 EPS next 5Y-1.80% ROE13.60% 52W Range25.39 - 38.64 Perf YTD-15.49%
Dividend0.38 P/FCF69.84 EPS past 5Y40.50% ROI17.10% 52W High-21.38% Beta1.18
Dividend %1.25% Quick Ratio3.50 Sales past 5Y10.30% Gross Margin68.10% 52W Low19.65% ATR1.23
Employees457 Current Ratio5.20 Sales Q/Q20.20% Oper. Margin19.00% RSI (14)33.33 Volatility2.01% 3.73%
OptionableYes Debt/Eq0.00 EPS Q/Q19.70% Profit Margin15.80% Rel Volume0.65 Prev Close30.74
ShortableYes LT Debt/Eq0.00 EarningsFeb 06 AMC Payout31.30% Avg Volume127.94K Price30.38
Recom2.40 SMA20-9.04% SMA50-13.43% SMA200-6.02% Volume85,781 Change-1.17%
Oct-24-19Upgrade Lake Street Hold → Buy $40
Oct-24-19Downgrade First Analysis Sec Strong Buy → Outperform $37 → $40
Oct-14-19Upgrade First Analysis Sec Outperform → Strong Buy $37
Jul-25-19Upgrade First Analysis Sec Neutral → Outperform $29 → $37
Jul-25-19Reiterated Barrington Research Outperform $32 → $37
Oct-08-18Upgrade ROTH Capital Neutral → Buy
Oct-08-18Upgrade Barrington Research Mkt Perform → Outperform $34
Jun-08-18Resumed ROTH Capital Buy $38
Apr-26-18Upgrade The Benchmark Company Hold → Buy $40
Apr-26-18Downgrade Stifel Buy → Hold $40 → $34
Oct-27-17Downgrade The Benchmark Company Buy → Hold
Oct-27-17Downgrade First Analysis Sec Overweight → Equal-Weight $34
Jul-10-17Downgrade The Benchmark Company Buy → Hold
Jul-10-17Downgrade Canaccord Genuity Buy → Hold $28
Mar-21-17Initiated First Analysis Sec Overweight $29
Feb-22-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-22-16Downgrade Sidoti Buy → Neutral
Jul-28-16Reiterated Barrington Research Outperform $18.50 → $20
Feb-25-16Reiterated Barrington Research Outperform $14 → $15.50
Feb-08-16Upgrade Sidoti Neutral → Buy
Feb-18-20 12:28PM  LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 GlobeNewswire
Feb-13-20 10:38AM  Walgreens U.S. Retail Pharmacy Rises Amid Reimbursement Woes Zacks
06:44AM  Edited Transcript of LMAT earnings conference call or presentation 6-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-11-20 10:41AM  LabCorp (LH) Rides on Solid Diagnostics Despite PAMA Issues Zacks
Feb-10-20 09:28AM  Here's Why You Should Add Zimmer (ZBH) to Your Portfolio Zacks
08:34AM  Hologic Expands Panther Portfolio With New Product Offerings Zacks
Feb-09-20 08:42AM  LeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Feb-07-20 07:32AM  The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga -19.51%
Feb-06-20 06:25PM  LeMaitre Vascular (LMAT) Q4 Earnings Match Estimates Zacks
04:05PM  LeMaitre Vascular Announces Q4 2019 Financial Results GlobeNewswire
Jan-30-20 12:31PM  Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-29-20 02:13PM  LeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020 GlobeNewswire
Jan-26-20 05:36PM  3 Stocks With Fast-Growing Earnings GuruFocus.com
Jan-22-20 08:59AM  Shareholders Are Raving About How The LeMaitre Vascular (NASDAQ:LMAT) Share Price Increased 368% Simply Wall St.
Jan-10-20 05:00AM  Top Picks 2020- LeMaitre Vascular LMAT MoneyShow
Jan-03-20 11:45AM  LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020 GlobeNewswire
Jan-02-20 02:12PM  Does LeMaitre Vascular, Inc. (NASDAQ:LMAT) Have A Volatile Share Price? Simply Wall St.
Dec-14-19 07:18PM  Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy? Insider Monkey
Dec-09-19 12:46PM  Why LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Quality Company Simply Wall St.
Nov-19-19 08:16AM  Shareholders Are Loving LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 1.0% Yield Simply Wall St.
Nov-15-19 06:35PM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Nov-14-19 09:30AM  EYE vs. LMAT: Which Stock Is the Better Value Option? Zacks
Oct-30-19 08:34PM  Did Hedge Funds Drop The Ball On LeMaitre Vascular Inc (LMAT) ? Insider Monkey
09:22AM  Don't Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT) Simply Wall St.
Oct-29-19 04:26PM  Here's Why You Should Add ResMed (RMD) to Your Portfolio Zacks
05:29AM  Edited Transcript of LMAT earnings conference call or presentation 23-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Oct-23-19 05:25PM  LeMaitre Vascular (LMAT) Q3 Earnings and Revenues Beat Estimates Zacks
04:05PM  LeMaitre Vascular Announces Q3 2019 Financial Results GlobeNewswire
Oct-16-19 10:32AM  LeMaitre Vascular (LMAT) Reports Next Week: What to Know Ahead of the Release Zacks
Oct-14-19 10:45AM  Are Insiders Selling LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock? Simply Wall St.
Oct-13-19 07:00PM  LeMaitre Vascular Acquires Biologic Patch Business from Admedus GlobeNewswire
Oct-11-19 03:36PM  LeMaitre Vascular Will Announce Third Quarter 2019 Earnings Results on October 23, 2019 GlobeNewswire
Oct-02-19 09:30AM  EYE vs. LMAT: Which Stock Should Value Investors Buy Now? Zacks
Sep-24-19 08:20AM  LeMaitre Vascular, Inc. (NASDAQ:LMAT) Earns Among The Best Returns In Its Industry Simply Wall St.
Sep-13-19 09:15PM  Lemaitre Vascular Inc (LMAT) Chairman and CEO George W Lemaitre Sold $1.3 million of Shares GuruFocus.com
Sep-06-19 08:35AM  Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks
Sep-05-19 07:17AM  Here's Why You Should Invest in Edwards Lifesciences (EW) Now Zacks
Sep-04-19 06:45AM  Is LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) CEO Paid Enough Relative To Peers? Simply Wall St.
Aug-27-19 08:56AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Zacks
Aug-26-19 09:00AM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Aug-23-19 08:37AM  Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety Zacks
Aug-22-19 07:31AM  NuVasive's New TLIF Implant Broadens Spine Surgery Option Zacks
Aug-20-19 09:03AM  Boston Scientific's (BSX) Vercise Gevia DBS Gets FDA Nod Zacks
Aug-17-19 08:18AM  LeMaitre Vascular, Inc. (NASDAQ:LMAT)'s Could Be A Buy For Its Upcoming Dividend Simply Wall St.
Aug-14-19 09:33AM  Myriad Genetics (MYGN) Q4 Earnings Lag Estimates, Revenues Up Zacks
Aug-12-19 08:41AM  National Vision (EYE) Q2 Earnings Lag Estimates, Margins Down Zacks
Aug-09-19 07:32AM  Haemonetics (HAE) Beats on Q1 Earnings, Raises '19 EPS View Zacks
Aug-03-19 09:50AM  Why LeMaitre Vascular, Inc. (NASDAQ:LMAT) Could Be Worth Watching Simply Wall St.
Jul-30-19 12:29PM  LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019 GlobeNewswire
Jul-29-19 10:10AM  Moving Average Crossover Alert: LeMaitre Vascular Zacks
Jul-26-19 06:15PM  Lemaitre Vascular Inc (LMAT) Chairman and CEO George W Lemaitre Sold $2.3 million of Shares GuruFocus.com
05:42AM  Edited Transcript of LMAT earnings conference call or presentation 24-Jul-19 9:00pm GMT Thomson Reuters StreetEvents
Jul-25-19 07:21AM  The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug Benzinga
03:24AM  LeMaitre Vascular (LMAT) Q2 2019 Earnings Call Transcript Motley Fool
Jul-24-19 06:15PM  LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:05PM  LeMaitre Vascular Announces Q2 2019 Financial Results GlobeNewswire
Jul-17-19 10:32AM  Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-16-19 09:05AM  Did You Miss LeMaitre Vascular's (NASDAQ:LMAT) Impressive 271% Share Price Gain? Simply Wall St.
Jul-11-19 05:27PM  LeMaitre Vascular Will Announce Second Quarter 2019 Earnings Results on July 24, 2019 GlobeNewswire
Jul-01-19 01:00PM  Does This Valuation Of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Imply Investors Are Overpaying? Simply Wall St.
Jun-28-19 07:56PM  Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy? Insider Monkey
Jun-21-19 09:30AM  Healthcare: 3 Little-Known Medical Device Makers Motley Fool
Jun-13-19 10:28AM  Here's Why I Think LeMaitre Vascular (NASDAQ:LMAT) Might Deserve Your Attention Today Simply Wall St.
May-29-19 03:06PM  How Does LeMaitre Vascular, Inc. (NASDAQ:LMAT) Fare As A Dividend Stock? Simply Wall St.
01:43PM  LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Thursday, June 6, 2019 GlobeNewswire
May-13-19 04:08PM  Edited Transcript of LMAT earnings conference call or presentation 1-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-09-19 08:21PM  Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy? Insider Monkey
May-06-19 04:15PM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
May-02-19 02:23AM  LeMaitre Vascular (LMAT) Q1 2019 Earnings Call Transcript Motley Fool -9.30%
May-01-19 07:15PM  LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates Zacks
06:11PM  LeMaitre: 1Q Earnings Snapshot Associated Press
04:05PM  LeMaitre Vascular Announces Q1 2019 Financial Results GlobeNewswire
Apr-24-19 04:15PM  LeMaitre Vascular Will Announce First Quarter 2019 Earnings Results on May 1, 2019 GlobeNewswire
Apr-22-19 08:55AM  What Should We Expect From LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Earnings In The Next 12 Months? Simply Wall St.
Apr-17-19 11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks -5.48%
10:32AM  LeMaitre Vascular (LMAT) Q1 Earnings Preview: What's in the Cards? Zacks
Apr-07-19 10:47AM  Have Insiders Been Selling LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares? Simply Wall St.
Mar-23-19 10:53AM  LeMaitre Vascular, Inc. (NASDAQ:LMAT) Has Attractive Fundamentals Simply Wall St.
Mar-11-19 07:48PM  LeMaitre Vascular Inc (LMAT) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-09-19 08:56AM  Where LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stands In Terms Of Earnings Growth Against Its Industry Simply Wall St.
Mar-08-19 02:48PM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Feb-23-19 08:30AM  A Close Look At LeMaitre Vascular, Inc.s (NASDAQ:LMAT) 16% ROCE Simply Wall St.
Feb-22-19 08:30AM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Feb-20-19 09:40PM  Edited Transcript of LMAT earnings conference call or presentation 19-Feb-19 10:00pm GMT Thomson Reuters StreetEvents +22.59%
11:18AM  Why LeMaitre Vascular Is Soaring Motley Fool
07:34AM  The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering Benzinga
Feb-19-19 09:47PM  LeMaitre Vascular inc (LMAT) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:55PM  LeMaitre: 4Q Earnings Snapshot Associated Press
04:05PM  LeMaitre Vascular Announces Q4 2018 Financial Results GlobeNewswire
03:00PM  LeMaitre Vascular, Inc. to Host Earnings Call ACCESSWIRE
Feb-18-19 05:00AM  LeMaitre Vascular- Heart-Felt Opportunity MoneyShow
Feb-12-19 10:30AM  LeMaitre Vascular (LMAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-06-19 04:30PM  LeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019 GlobeNewswire
07:18AM  Our Take On LeMaitre Vascular, Inc.s (NASDAQ:LMAT) CEO Salary Simply Wall St.
Jan-22-19 06:53AM  Estimating The Intrinsic Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Simply Wall St.
Jan-08-19 05:17PM  LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 16, 2019 GlobeNewswire
Jan-07-19 06:37AM  How Does Investing In LeMaitre Vascular, Inc. (NASDAQ:LMAT) Impact The Volatility Of Your Portfolio? Simply Wall St.
Dec-19-18 02:56PM  Investors In LeMaitre Vascular, Inc. (NASDAQ:LMAT) Should Consider This Data Simply Wall St.
Dec-04-18 02:53PM  Should You Think About Buying LeMaitre Vascular Inc (NASDAQ:LMAT) Now? Simply Wall St.
Nov-16-18 02:36PM  Is LeMaitre Vascular Inc (NASDAQ:LMAT) A High Quality Stock To Own? Simply Wall St.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. LeMaitre Vascular, Inc. markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LeMaitre George WChairman and CEOJan 13Sale37.551,93972,80530,000Jan 15 05:49 PM
LeMaitre George WChairman and CEOJan 09Sale37.423,023113,13331,939Jan 09 05:55 PM
LeMaitre George WChairman and CEOJan 08Sale36.8112,440457,9202,939,726Jan 09 05:55 PM
LeMaitre George WChairman and CEOJan 07Sale36.6127,302999,5702,952,166Jan 09 05:55 PM
Pellegrino Joseph P JRChief Financial OfficerJan 03Sale36.073,231116,5557,080Jan 06 04:23 PM
Pellegrino Joseph P JRChief Financial OfficerJan 02Sale36.0771025,60710,311Jan 02 08:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 31Sale36.101,10539,89411,021Jan 02 08:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 30Sale36.116,265226,20012,126Dec 30 05:05 PM
LeMaitre George WChairman and CEODec 27Sale36.454,894178,3892,979,468Dec 31 05:41 PM
Pellegrino Joseph P JRChief Financial OfficerDec 27Sale36.219,748352,95618,391Dec 30 05:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 26Sale36.051,41250,90928,139Dec 30 05:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 24Sale36.0730010,82229,551Dec 26 10:48 AM
LeMaitre George WChairman and CEODec 22Option Exercise0.001602,984,884Dec 26 11:52 AM
Kamke Trent GSenior V. P., OperationsDec 22Option Exercise0.004031,638Dec 26 11:17 AM
Roberts David BPresident and DirectorDec 22Option Exercise0.006036,841Dec 26 10:54 AM
Pellegrino Joseph P JRChief Financial OfficerDec 22Option Exercise0.006030,032Dec 26 10:48 AM
Pellegrino Joseph P JRChief Financial OfficerDec 19Option Exercise0.005031,054Dec 23 08:20 PM
LeMaitre George WChairman and CEODec 19Option Exercise0.001702,980,450Dec 23 08:54 PM
Kamke Trent GSenior V. P., OperationsDec 19Option Exercise0.004030,897Dec 23 08:36 PM
Roberts David BPresident and DirectorDec 19Option Exercise0.005035,231Dec 23 08:28 PM
Pellegrino Joseph P JRChief Financial OfficerDec 19Sale36.052,785100,39728,264Dec 23 08:20 PM
Pellegrino Joseph P JRChief Financial OfficerDec 18Sale36.1010,442376,93331,049Dec 18 09:07 PM
Pellegrino Joseph P JRChief Financial OfficerDec 16Sale36.176,068219,50541,491Dec 18 09:07 PM
LeMaitre George WChairman and CEODec 16Sale36.404,759173,2382,980,433Dec 18 08:58 PM
Pellegrino Joseph P JRChief Financial OfficerDec 06Sale36.004,154149,54447,559Dec 09 04:43 PM
Pellegrino Joseph P JRChief Financial OfficerDec 05Sale36.002,796100,65651,713Dec 05 05:57 PM
LeMaitre George WChairman and CEODec 04Sale36.3211,241408,3002,985,192Dec 06 07:50 PM
Pellegrino Joseph P JRChief Financial OfficerDec 04Sale36.0067,7182,438,00454,509Dec 05 05:57 PM
Pellegrino Joseph P JRChief Financial OfficerDec 03Sale36.0050,6451,823,220122,227Dec 05 05:57 PM
Roberts David BPresident and DirectorNov 27Option Exercise11.436,90678,93642,132Nov 27 06:14 PM
Roberts David BPresident and DirectorNov 27Sale35.826,906247,34735,226Nov 27 06:14 PM
LeMaitre George WChairman and CEONov 26Sale36.252,906105,3472,996,433Nov 27 05:48 PM
Pellegrino Joseph P JRChief Financial OfficerNov 25Option Exercise12.5064,792810,195237,664Nov 27 05:41 PM
LeMaitre George WChairman and CEONov 25Sale36.1224,200874,0102,999,339Nov 27 05:48 PM
Pellegrino Joseph P JRChief Financial OfficerNov 25Sale35.8864,7922,324,478172,872Nov 27 05:41 PM
Pellegrino Joseph P JRChief Financial OfficerNov 22Option Exercise7.8725,945204,187198,817Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 22Sale35.0925,945910,387172,872Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 21Option Exercise7.875,74545,213178,617Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 21Sale35.015,745201,114172,872Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 20Option Exercise7.8711,18288,002184,054Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 20Sale35.0111,182391,468172,872Nov 22 04:42 PM
LeMaitre George WChairman and CEONov 08Sale33.5316,051538,2003,024,394Nov 12 04:41 PM
LeMaitre George WChairman and CEONov 05Sale34.138,105276,6463,040,445Nov 05 06:35 PM
LeMaitre George WChairman and CEONov 04Sale34.505,519190,4243,048,550Nov 05 06:35 PM
LeMaitre George WChairman and CEONov 01Sale34.8614,684511,8463,054,069Nov 05 06:35 PM
LeMaitre George WChairman and CEOOct 31Sale35.541,79663,8213,068,753Oct 31 06:47 PM
LeMaitre George WChairman and CEOOct 30Sale35.539,921352,4913,070,549Oct 31 06:47 PM
LeMaitre George WChairman and CEOOct 29Sale35.599,217328,0173,080,470Oct 31 06:47 PM
LeMaitre George WChairman and CEOOct 28Sale35.537,348261,0653,089,687Oct 28 05:55 PM
Roberts David BPresident and DirectorOct 28Sale35.2912,202430,62735,226Oct 30 05:15 PM
LeMaitre George WChairman and CEOOct 24Sale37.177,068262,73234,962Oct 28 05:55 PM
Roberts David BPresident and DirectorOct 18Option Exercise8.7611,41999,99647,428Oct 22 05:40 PM
Pellegrino Joseph P JRChief Financial OfficerSep 23Option Exercise6.672,48916,602175,361Sep 23 04:50 PM
Pellegrino Joseph P JRChief Financial OfficerSep 23Sale35.092,48987,328172,872Sep 23 04:50 PM
Pellegrino Joseph P JRChief Financial OfficerSep 20Option Exercise6.6723,905159,446196,777Sep 23 04:50 PM
Pellegrino Joseph P JRChief Financial OfficerSep 20Sale35.2723,905843,027172,872Sep 23 04:50 PM
Pellegrino Joseph P JRChief Financial OfficerSep 19Option Exercise6.6722,650151,076195,522Sep 23 04:50 PM
Pellegrino Joseph P JRChief Financial OfficerSep 19Sale35.7022,650808,619172,872Sep 23 04:50 PM
LeMaitre George WChairman and CEOSep 13Sale35.034,891171,3223,097,035Sep 13 07:36 PM
LeMaitre George WChairman and CEOSep 12Sale34.8433,4721,166,0343,101,926Sep 13 07:36 PM
LeMaitre George WChairman and CEOSep 11Sale34.6733211,5103,135,398Sep 13 07:36 PM
Thomas Michael HDirectorAug 09Option Exercise11.437,50085,72515,000Aug 13 04:02 PM
Thomas Michael HDirectorAug 09Sale32.1015,000481,5600Aug 13 04:02 PM
Jasinski Lawrence JDirectorAug 06Option Exercise13.237,50099,22515,833Aug 08 04:34 PM
Jasinski Lawrence JDirectorAug 06Sale32.005,000160,0008,333Aug 08 04:34 PM
LeMaitre George WChairman and CEOAug 01Sale32.722,00065,44942,031Aug 01 05:24 PM
LeMaitre George WChairman and CEOJul 31Sale33.076,000198,43744,031Aug 01 05:24 PM
LeMaitre George WChairman and CEOJul 30Sale32.542,00065,07550,031Aug 01 05:24 PM
LeMaitre George WChairman and CEOJul 25Option Exercise14.0931,822448,3873,202,857Jul 26 04:42 PM
Roberts David BPresident and DirectorJul 25Option Exercise0.0027036,278Jul 29 04:32 PM
Pellegrino Joseph P JRChief Financial OfficerJul 25Option Exercise0.00280173,141Jul 29 04:24 PM
Kamke Trent GSenior V. P., OperationsJul 25Option Exercise0.0014031,017Jul 29 04:13 PM
LeMaitre George WChairman and CEOJul 25Sale34.4566,0372,275,1993,136,820Jul 26 04:42 PM
LeMaitre George WChairman and CEOJul 24Option Exercise12.5723,621296,9163,171,124Jul 26 04:42 PM
O'Connor John JamesDirectorJul 16Option Exercise7.877,50059,02576,210Jul 17 05:19 PM
Thomas Michael HDirectorJul 09Option Exercise7.877,50059,0257,500Jul 11 04:32 PM
LeMaitre George WChairman and CEOJun 24Option Exercise7.8730,972243,7503,147,503Jun 25 06:59 PM
Pellegrino Joseph P JRChief Financial OfficerJun 17Option Exercise6.2346,060286,954173,113Jun 19 04:59 PM
Roush John ADirectorMar 13Option Exercise8.0120,000160,20020,000Mar 15 04:22 PM
Kamke Trent GSenior V. P., OperationsFeb 26Option Exercise7.8711,14687,71931,003Feb 26 04:18 PM